Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 10/20 | 0.83 |
| ▸ | LMNA | P02545 | 3/20 | 0.83 |
| ▸ | PDE4A | P27815 | 1/20 | 0.73 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.73 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.73 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8697228 | 0.95 | ADORA2B (0.81) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL10856641 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL9293748 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL10652746 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL8070551 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL9293800 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL9293922 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL9294691 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| SCHEMBL9294488 | 0.94 | ADORA2B (0.78) | ADORA2BLMNAPDE4APDE4BPDE4C | |
| Etofylline SCHEMBL149271 | 0.91 | ADORA2B (1.00) | ADORA2BLMNAPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122023257-A | Russian circuit board failure analysis method | 西安益翔航电科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-118772316-A | Cyclodextrin rotaxane functionalized graphene nanocomposite and preparation and application thereof | 山西大学 | 2024-10-15 | — | — | CN | claimed |
| CN-116343338-A | Human skeleton action recognition method based on hierarchical space-time attention network | 西安电子科技大学 | 2023-06-27 | — | — | CN | claimed |
| US-4117132-A | PROCESS FOR THE PRODUCTION OF STABILIZED PURE THEOPHYLLINE IN NEUTRAL, AQUEOUS SOLUTION | DR. ADOLF SEEBACH AG (CH) | 1978-09-26 | — | — | US | claimed |
| CN-122023257-A | Russian circuit board failure analysis method | 西安益翔航电科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-118772316-A | Cyclodextrin rotaxane functionalized graphene nanocomposite and preparation and application thereof | 山西大学 | 2024-10-15 | — | — | CN | disclosed |
| CN-118772316-A | Cyclodextrin rotaxane functionalized graphene nanocomposite and preparation and application thereof | 山西大学 | 2024-10-15 | — | — | CN | disclosed |
| CN-115059049-B | Application of quick-drying cement in frozen soil grouting and grouting method containing application | 中交第三航务工程局有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-116851033-A | Supported solid-phase tetrapeptide catalyst and preparation method and application thereof | 兰州大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116343338-A | Human skeleton action recognition method based on hierarchical space-time attention network | 西安电子科技大学 | 2023-06-27 | — | — | CN | disclosed |
| US-11249312-B2 | Color-corrected curved optical see-through thin lightguide with large field of view in eyewear formfactor | GOOGLE LLC (US) | 2022-02-15 | — | — | US | disclosed |
| US-5288721-A | Substituted epoxyalkyl xanthines | CELL THERAPEUTICS, INC. (US) | 1994-02-22 | — | — | US | disclosed |
| US-4618612-A | ANTICOAGULANTS, ANTIINFLAMMATORY AGENTS, BRONCHODILATOR AGENTS | MEDOSAN INDUSTRIE BIOCHIMICHE RIUNITE S.P.A. (IT) | 1986-10-21 | — | — | US | disclosed |
| EP-0177659-A1 | Ester derivatives of 7-(omega-oxyalkyl) theophylline and their pharmaceutical activity | Medosan Industrie Biochimiche Riunite S.p.A. (IT) | 1986-04-16 | — | — | EP | disclosed |
| US-4581359-A | FOR BRONCHOPULMONARY INSUFFUCIENCY | THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1986-04-08 | — | — | US | disclosed |
| US-4542137-A | NONEXPLOSIVE, CARDIOVASCULAR | DR. WILLMAR SCHWABE GMBH & CO. (DE) | 1985-09-17 | — | — | US | disclosed |
| EP-0044927-B1 | ALKYLAMINO-DESOXY-1,4;3,6-DIANHYDRO-HEXITE-NITRATE SUBSTITUTED BY PURINE BASES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS | Dr. Willmar Schwabe GmbH & Co. (DE) | 1984-11-28 | — | — | EP | disclosed |
| EP-0044927-A1 | Alkylamino-desoxy-1,4;3,6-dianhydro-hexite-nitrate substituted by purine bases, process for their preparation and their pharmaceutical compositions | Dr. Willmar Schwabe GmbH & Co. (DE) | 1982-02-03 | — | — | EP | disclosed |
| US-4117132-A | PROCESS FOR THE PRODUCTION OF STABILIZED PURE THEOPHYLLINE IN NEUTRAL, AQUEOUS SOLUTION | DR. ADOLF SEEBACH AG (CH) | 1978-09-26 | — | — | US | disclosed |
| US-4031218-A | BRONCHODILATOR | MALLINCKRODT, INC. (US) | 1977-06-21 | — | — | US | disclosed |